ORBIMED ADVISORS LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$8.8T
Holdings
136
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (136 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,360,224 | $8.7B | 0.10% | |
| 102 | CLLSCELLECTIS S A | 350,000 | $8.4B | 0.10% | |
| 103 | —PORTOLA PHARMACEUTICALS INC | 370,900 | $8.4B | 0.10% | |
| 104 | —INCYTE CORP | 4,250,000 | $8.3B | 0.09% | |
| 105 | SIENUSDSIENTRA INC | 917,500 | $8.2B | 0.09% | |
| 106 | NUVAGBPNUVASIVE INC | 123,500 | $8.2B | 0.09% | |
| 107 | XENEXENON PHARMACEUTICALS INC | 1,000,000 | $8.1B | 0.09% | |
| 108 | —INCYTE CORP | 4,250,000 | $8.1B | 0.09% | |
| 109 | NERVGBPMINERVA NEUROSCIENCES INC | 556,200 | $7.9B | 0.09% | |
| 110 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $7.8B | 0.09% | |
| 111 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $6.2B | 0.07% | |
| 112 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 724,184 | $5.1B | 0.06% | |
| 113 | INFIQINFINITY PHARMACEUTICALS INC | 3,250,300 | $5.1B | 0.06% | |
| 114 | —GW PHARMACEUTICALS PLC | 36,200 | $4.8B | 0.05% | |
| 115 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $4.8B | 0.05% | |
| 116 | NVTA1EURINVITAE CORP | 456,666 | $4.0B | 0.05% | |
| 117 | GBYSANGAMO BIOSCIENCES INC | 831,500 | $3.9B | 0.04% | |
| 118 | QUREUNIQURE NV | 489,000 | $3.7B | 0.04% | |
| 119 | —PERNIX THERAPEUTICS HLDGS IN | 12,000,000 | $3.5B | 0.04% | |
| 120 | AMEDAMEDISYS INC | 71,500 | $3.4B | 0.04% | |
| 121 | —ROKA BIOSCIENCE INC | 3,220,429 | $2.2B | 0.03% | |
| 122 | —COGENTIX MED INC | 878,145 | $1.6B | 0.02% | |
| 123 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $1.4B | 0.02% | |
| 124 | ITCIEURINTRA CELLULAR THERAPIES INC | 90,000 | $1.4B | 0.02% | Call |
| 125 | —BIOLINERX LTD | 1,038,600 | $1.2B | 0.01% | |
| 126 | AMRNAMARIN CORP PLC | 350,000 | $1.1B | 0.01% | |
| 127 | —MARINUS PHARMACEUTICALS INC | 567,600 | $1.0B | 0.01% | |
| 128 | —QLT INC | 500,000 | $1.0B | 0.01% | |
| 129 | —MEDIGUS LTD | 600,000 | $756.0M | 0.01% | |
| 130 | —PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | $668.0M | 0.01% | |
| 131 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $624.0M | 0.01% | |
| 132 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $600.0M | 0.01% | |
| 133 | —XTANT MED HLDGS INC | 475,439 | $537.0M | 0.01% | |
| 134 | —NIVALIS THERAPEUTICS INC | 59,000 | $480.0M | 0.01% | |
| 135 | —ALIMERA SCIENCES INC | 250,000 | $373.0M | 0.00% | |
| 136 | —ARALEZ PHARMACEUTICALS INC | 68,143 | $330.0M | 0.00% |
PreviousPage 2 of 2